Foxway and Minerva Imaging: Pioneering Paths in Circular Tech and Radiopharmaceuticals
June 12, 2025, 6:02 am
In the fast-paced world of technology and healthcare, two companies are making waves. Foxway, a leader in circular tech solutions, is redefining sustainability in the tech sector. Meanwhile, Minerva Imaging is carving out a niche in the radiopharmaceutical space, aiming to revolutionize cancer treatment. Both companies are on growth trajectories, fueled by strategic partnerships and leadership changes.
Foxway is not just another tech company. It’s a beacon of sustainability. With a focus on circular tech solutions, Foxway is reshaping how organizations approach technology. The company’s recent leadership changes signal a commitment to this vision. Carl-Fredrik Lidman and Steinar Aune are stepping into pivotal roles. Lidman will lead the Circular Workplace Solutions unit, while Aune takes charge of Recommerce Computer & Enterprise. These appointments are not mere changes; they are strategic moves designed to enhance customer focus and drive growth.
The tech landscape is shifting. Customers are increasingly demanding responsible consumption. They want technology that not only meets their needs but also aligns with their values. Foxway recognizes this shift. The company’s refined strategy emphasizes sustainability and long-term value. It’s about more than just profits; it’s about setting new standards in circularity. This approach positions Foxway as a leader in the European market, catering to organizations seeking smarter tech choices.
Foxway’s journey took a significant turn in 2023 with a majority acquisition by Nordic Capital. This partnership has been transformative. It has allowed Foxway to enhance its strategy, focusing on delivering sustainable solutions across the entire value chain. From procurement to repair, and remarketing to reuse, Foxway is committed to a circular model that benefits both businesses and the environment.
The leadership changes are crucial for executing this strategy. Aune’s extensive experience in scaling businesses will be instrumental in expanding Foxway’s recommerce operations across Europe. His track record speaks volumes. Lidman’s background in strategic consulting and telecom will drive service innovation in circular workplace technology. Together, they form a leadership team poised to guide Foxway into a sustainable future.
On the other side of the spectrum, Minerva Imaging is making strides in the healthcare sector. This company specializes in radiopharmaceuticals, a rapidly growing field in cancer treatment. Minerva is not just a player; it’s a frontrunner. The partnership with Nordic Capital aims to accelerate its growth and enhance its service offerings. This collaboration is a testament to the potential of radiopharmaceuticals in modern medicine.
Minerva Imaging operates as both a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO). This dual role allows it to provide comprehensive services in the development of targeted radioligand therapies. These therapies are at the forefront of cancer treatment, offering precision and effectiveness. Minerva’s integrated platform combines scientific excellence with end-to-end service capabilities, making it a valuable partner for pharmaceutical and biotechnology companies.
The global radiopharmaceutical market is on the brink of significant growth. Increasing cancer incidence and a demand for precision medicine are driving this expansion. Minerva is well-positioned to capitalize on these trends. With Nordic Capital’s support, the company can scale its operations and enhance its scientific capabilities. This partnership is not just about financial backing; it’s about leveraging expertise to drive innovation.
Minerva’s leadership is equally impressive. The company employs over 150 skilled professionals, including many PhD-level scientists. This talent pool is crucial for advancing research and development in radiopharmaceuticals. The company’s commitment to scientific excellence is evident in its rapid growth, generating over DKK 225 million in revenue in 2024.
Both Foxway and Minerva Imaging share a common thread: a commitment to innovation and sustainability. Foxway is transforming the tech landscape with its circular solutions, while Minerva is revolutionizing cancer treatment through advanced radiopharmaceuticals. Their partnerships with Nordic Capital are strategic moves that enhance their capabilities and position them for future growth.
As these companies forge ahead, they exemplify the power of strategic leadership and innovation. Foxway’s focus on sustainability and Minerva’s dedication to precision medicine are not just trends; they are the future. In a world increasingly driven by responsible consumption and advanced healthcare solutions, these companies are leading the charge.
The journey is just beginning. Foxway and Minerva Imaging are not merely reacting to market demands; they are shaping the future. Their leadership changes and strategic partnerships are paving the way for new standards in their respective fields. As they continue to grow, they will undoubtedly influence the broader landscape of technology and healthcare.
In conclusion, Foxway and Minerva Imaging are shining examples of how companies can thrive in a competitive environment. With a focus on sustainability and innovation, they are not just keeping pace; they are setting the pace. The future looks bright for these pioneers, and their journeys will be closely watched as they continue to make an impact in their industries.
Foxway is not just another tech company. It’s a beacon of sustainability. With a focus on circular tech solutions, Foxway is reshaping how organizations approach technology. The company’s recent leadership changes signal a commitment to this vision. Carl-Fredrik Lidman and Steinar Aune are stepping into pivotal roles. Lidman will lead the Circular Workplace Solutions unit, while Aune takes charge of Recommerce Computer & Enterprise. These appointments are not mere changes; they are strategic moves designed to enhance customer focus and drive growth.
The tech landscape is shifting. Customers are increasingly demanding responsible consumption. They want technology that not only meets their needs but also aligns with their values. Foxway recognizes this shift. The company’s refined strategy emphasizes sustainability and long-term value. It’s about more than just profits; it’s about setting new standards in circularity. This approach positions Foxway as a leader in the European market, catering to organizations seeking smarter tech choices.
Foxway’s journey took a significant turn in 2023 with a majority acquisition by Nordic Capital. This partnership has been transformative. It has allowed Foxway to enhance its strategy, focusing on delivering sustainable solutions across the entire value chain. From procurement to repair, and remarketing to reuse, Foxway is committed to a circular model that benefits both businesses and the environment.
The leadership changes are crucial for executing this strategy. Aune’s extensive experience in scaling businesses will be instrumental in expanding Foxway’s recommerce operations across Europe. His track record speaks volumes. Lidman’s background in strategic consulting and telecom will drive service innovation in circular workplace technology. Together, they form a leadership team poised to guide Foxway into a sustainable future.
On the other side of the spectrum, Minerva Imaging is making strides in the healthcare sector. This company specializes in radiopharmaceuticals, a rapidly growing field in cancer treatment. Minerva is not just a player; it’s a frontrunner. The partnership with Nordic Capital aims to accelerate its growth and enhance its service offerings. This collaboration is a testament to the potential of radiopharmaceuticals in modern medicine.
Minerva Imaging operates as both a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO). This dual role allows it to provide comprehensive services in the development of targeted radioligand therapies. These therapies are at the forefront of cancer treatment, offering precision and effectiveness. Minerva’s integrated platform combines scientific excellence with end-to-end service capabilities, making it a valuable partner for pharmaceutical and biotechnology companies.
The global radiopharmaceutical market is on the brink of significant growth. Increasing cancer incidence and a demand for precision medicine are driving this expansion. Minerva is well-positioned to capitalize on these trends. With Nordic Capital’s support, the company can scale its operations and enhance its scientific capabilities. This partnership is not just about financial backing; it’s about leveraging expertise to drive innovation.
Minerva’s leadership is equally impressive. The company employs over 150 skilled professionals, including many PhD-level scientists. This talent pool is crucial for advancing research and development in radiopharmaceuticals. The company’s commitment to scientific excellence is evident in its rapid growth, generating over DKK 225 million in revenue in 2024.
Both Foxway and Minerva Imaging share a common thread: a commitment to innovation and sustainability. Foxway is transforming the tech landscape with its circular solutions, while Minerva is revolutionizing cancer treatment through advanced radiopharmaceuticals. Their partnerships with Nordic Capital are strategic moves that enhance their capabilities and position them for future growth.
As these companies forge ahead, they exemplify the power of strategic leadership and innovation. Foxway’s focus on sustainability and Minerva’s dedication to precision medicine are not just trends; they are the future. In a world increasingly driven by responsible consumption and advanced healthcare solutions, these companies are leading the charge.
The journey is just beginning. Foxway and Minerva Imaging are not merely reacting to market demands; they are shaping the future. Their leadership changes and strategic partnerships are paving the way for new standards in their respective fields. As they continue to grow, they will undoubtedly influence the broader landscape of technology and healthcare.
In conclusion, Foxway and Minerva Imaging are shining examples of how companies can thrive in a competitive environment. With a focus on sustainability and innovation, they are not just keeping pace; they are setting the pace. The future looks bright for these pioneers, and their journeys will be closely watched as they continue to make an impact in their industries.